Eikon Therapeutics (EIKN) closed at $5.98 on November 13, 2026, down 1.0% from the previous close, on volume of 289,360 shares (30-day average 529,163).
Data as of November 13, 2026.
Eikon Therapeutics, Inc. (EIKN) Receives a Sell from Wedbush
TipRanks (Fri, 13-Nov 9:06 AM ET)
Eikon’s EIK1001 Advances into Registrational Studies; Price Target Remains $23
TipRanks (Thu, 12-Nov 10:35 AM ET)
Eikon Therapeutics, Inc. reports Q3 results
Seeking Alpha News (Thu, 12-Nov 6:43 AM ET)
Eikon Therapeutics Reports Third Quarter 2026 Financial Results and Provides Clinical Updates
Globe Newswire (Thu, 12-Nov 6:30 AM ET)
Eikon Therapeutics to Participate in Multiple Investor Conferences in November
Globe Newswire (Mon, 2-Nov 9:15 AM ET)
Globe Newswire (Mon, 26-Oct 6:00 AM ET)
Globe Newswire (Fri, 23-Oct 9:15 AM ET)
Globe Newswire (Sun, 18-Oct 6:05 PM ET)
Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer
Globe Newswire (Thu, 15-Oct 8:00 AM ET)
Globe Newswire (Thu, 3-Sep 7:30 AM ET)
Eikon Therapeutics Inc is a late-stage clinical biopharmaceutical company dedicated to building a world-wide , fully-integrated organization developing important, medicines to address serious unmet medical needs. It operates in a single operating segment, which is in the business of drug discovery leveraging its proprietary technology and clinical development of its product candidates. Its product candidates include: EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006.
Eikon Therapeutics trades on the NASDAQ stock market under the symbol EIKN.
As of November 13, 2026, EIKN stock price declined to $5.98 with 289,360 million shares trading.
EIKN has a beta of 1.48, meaning it tends to be more sensitive to market movements. EIKN has a correlation of 0.04 to the broad based SPY ETF.
EIKN has a market cap of $323.75 million. This is considered a Small Cap stock.
The top ETF exchange traded funds that EIKN belongs to (by Net Assets): VTI, IWM, VXF, VTWO, IWO.
EIKN support price is $5.62 and resistance is $6.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EIKN shares will trade within this expected range on the day.
